Format
Sort by
Items per page

Send to

Choose Destination

Best matches for D’Amico TA[au]:

Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology. Ettinger DS et al. J Natl Compr Canc Netw. (2017)

NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018. Ettinger DS et al. J Natl Compr Canc Netw. (2018)

Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology. Ajani JA et al. J Natl Compr Canc Netw. (2016)

Search results

Items: 1 to 50 of 321

1.

Commentary: Seeking the grail? Choose wisely.

D'Amico TA.

J Thorac Cardiovasc Surg. 2019 Sep 19. pii: S0022-5223(19)31828-8. doi: 10.1016/j.jtcvs.2019.07.141. [Epub ahead of print] No abstract available.

PMID:
31607493
2.

Outcomes of surgery versus chemoradiotherapy in patients with clinical or pathologic stage N3 non-small cell lung cancer.

Raman V, Jawitz OK, Yang CJ, Voigt SL, Wang H, D'Amico TA, Harpole DH, Tong BC.

J Thorac Cardiovasc Surg. 2019 Sep 9. pii: S0022-5223(19)31760-X. doi: 10.1016/j.jtcvs.2019.08.033. [Epub ahead of print]

PMID:
31606169
3.

Outcomes for Surgery in Large Cell Lung Neuroendocrine Cancer.

Raman V, Jawitz OK, Yang CJ, Voigt SL, Tong BC, D'Amico TA, Harpole DH.

J Thorac Oncol. 2019 Sep 23. pii: S1556-0864(19)33306-4. doi: 10.1016/j.jtho.2019.09.005. [Epub ahead of print]

PMID:
31557535
4.

Surgery is Associated with Survival Benefit in T4a Esophageal Adenocarcinoma: A National Analysis.

Raman V, Jawitz OK, Voigt SL, Farrow NE, Yang CJ, D'Amico TA, Harpole DH Jr.

Ann Thorac Surg. 2019 Jul 26. pii: S0003-4975(19)31060-4. doi: 10.1016/j.athoracsur.2019.05.091. [Epub ahead of print]

PMID:
31356800
5.

Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

Ajani JA, D'Amico TA, Bentrem DJ, Chao J, Corvera C, Das P, Denlinger CS, Enzinger PC, Fanta P, Farjah F, Gerdes H, Gibson M, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Johung KL, Keswani RN, Kleinberg LR, Leong S, Ly QP, Matkowskyj KA, McNamara M, Mulcahy MF, Paluri RK, Park H, Perry KA, Pimiento J, Poultsides GA, Roses R, Strong VE, Wiesner G, Willett CG, Wright CD, McMillian NR, Pluchino LA.

J Natl Compr Canc Netw. 2019 Jul 1;17(7):855-883. doi: 10.6004/jnccn.2019.0033.

PMID:
31319389
6.

Flow Cytometry Characterization of Cerebrospinal Fluid Monocytes in Patients With Postoperative Cognitive Dysfunction: A Pilot Study.

Berger M, Murdoch DM, Staats JS, Chan C, Thomas JP, Garrigues GE, Browndyke JN, Cooter M, Quinones QJ, Mathew JP, Weinhold KJ, Amundsen CL, Bengali S, Brigman BE, Bullock WM, Carter J, Chapman J, Cheong Yee Ching V, Cohen HJ, Colin B, D'Amico TA, Devinney MJ, DeOrio JK, Ellet T, Esclamado RM, Ferrandino MN, Gadsden J, Guercio J, Habib A, Harpole DH, Hartwig MG, Iboaya E, Inman BA, Khan A, Lagoo-Deenadayalan S, Lee PS, Lee WT, Lemm J, Levinson H, Mantyh C, McDonagh DL, Migaly J, Mithani SK, Moretti E, Moul JW, Newman MF, Ni K, Ohlendorf B, Perez A, Peterson AC, Ponussamy V, Preminger GM, Robertson CN, Roman SA, Runyon S, Sandler A, Scheri RP, Smith SK, Talbot L, Thacker JKM, Tong BC, Tu A, Vaslef SN, Waldron N, Wang X, Whitson H, Wickenheisser V, Young C; MADCO-PC Study Team; Markers of Alzheimer’s Disease and neuroCognitive Outcomes after Perioperative Care (MADCO-PC).

Anesth Analg. 2019 Nov;129(5):e150-e154. doi: 10.1213/ANE.0000000000004179.

PMID:
31085945
7.

Challenging 30-day mortality as a site-specific quality metric in non-small cell lung cancer.

Moore CB, Cox ML, Mulvihill MS, Klapper J, D'Amico TA, Hartwig MG.

J Thorac Cardiovasc Surg. 2019 Aug;158(2):570-578.e3. doi: 10.1016/j.jtcvs.2019.02.123. Epub 2019 Mar 28.

PMID:
31056356
8.

Adjuvant Therapy for Patients With Early Large Cell Lung Neuroendocrine Cancer: A National Analysis.

Raman V, Jawitz OK, Yang CJ, Tong BC, D'Amico TA, Berry MF, Harpole DH Jr.

Ann Thorac Surg. 2019 Aug;108(2):377-383. doi: 10.1016/j.athoracsur.2019.03.053. Epub 2019 Apr 18.

PMID:
31004586
9.

A National Analysis of Short-term Outcomes and Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Clinical Stage II Non-Small-Cell Lung Cancer.

Yang CJ, Kumar A, Deng JZ, Raman V, Lui NS, D'Amico TA, Berry MF.

Ann Surg. 2019 Mar 26. doi: 10.1097/SLA.0000000000003231. [Epub ahead of print]

PMID:
30946089
10.

A Nomogram for Predicting Cancer-Specific Survival of TNM 8th Edition Stage I Non-small-cell Lung Cancer.

Zeng Y, Mayne N, Yang CJ, D'Amico TA, Ng CSH, Liu CC, Petersen RH, Rocco G, Brunelli A, Liu J, Liu Y, Huang W, He J, Wang W, Jiang L, Cui F, Wang W, Liang W, He J; AME Thoracic Surgery Collaborative Group.

Ann Surg Oncol. 2019 Jul;26(7):2053-2062. doi: 10.1245/s10434-019-07318-7. Epub 2019 Mar 21.

PMID:
30900105
11.

The role of thoracoscopic pneumonectomy in the management of non-small cell lung cancer: A multicenter study.

Yang CJ, Yendamuri S, Mayne NR, Battoo A, Wang H, Meyerhoff RR, Vandusen K, Hirji SA, Berry MF, McKenna RJ Jr, Demmy TL, D'Amico TA.

J Thorac Cardiovasc Surg. 2019 Jul;158(1):252-264.e2. doi: 10.1016/j.jtcvs.2018.12.001. Epub 2018 Dec 18.

PMID:
30739773
12.

A young man with progressive esophageal neoplasms.

Shen Y, Shen J, Phan K, Tian D, D'Amico TA, Berry MF, Blackmon SH, Meyerson SL, D'Journo XB, Chen YJ, Baron G, Hou Y, Tan L; written on behalf of AME Esophageal Cancer Collaborative Group.

J Thorac Dis. 2018 Nov;10(11):5985-5990. doi: 10.21037/jtd.2018.10.56. No abstract available.

13.

Right-Sided Versus Left-Sided Pneumonectomy After Induction Therapy for Non-Small Cell Lung Cancer.

Yang CJ, Shah SA, Lin BK, VanDusen KW, Chan DY, Tan WD, Ranney DN, Cox ML, D'Amico TA, Berry MF.

Ann Thorac Surg. 2019 Apr;107(4):1074-1081. doi: 10.1016/j.athoracsur.2018.10.009. Epub 2018 Nov 15.

PMID:
30448482
14.

Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC.

Ackerson BG, Tong BC, Hong JC, Gu L, Chino J, Trotter JW, D'Amico TA, Torok JA, Lafata K, Chang C, Kelsey CR.

Lung Cancer. 2018 Nov;125:185-191. doi: 10.1016/j.lungcan.2018.09.020. Epub 2018 Sep 25.

PMID:
30429018
15.

Response to Comment on "A National Analysis of Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Stage I Nonsmall-cell Lung Cancer".

Yang CJ, Kumar A, Berry MF, D'Amico TA.

Ann Surg. 2019 Aug;270(2):e47. doi: 10.1097/SLA.0000000000003081. No abstract available.

PMID:
30407205
16.

The Aggressive Cholesterol Therapy to Inhibit Vein Graft Events trial: To continue or not? How to answer the question.

Moffatt-Bruce SD, D'Amico TA, Weisel RD, Sade RM.

J Thorac Cardiovasc Surg. 2019 Jan;157(1):164-165. doi: 10.1016/j.jtcvs.2018.09.066. Epub 2018 Oct 9. No abstract available.

PMID:
30396741
17.

Visiting an old foe: distant recurrence following R0 lobectomy for pathological N0 lung adenocarcinoma.

Hirji SA, D'Amico TA.

J Thorac Dis. 2018 Sep;10(Suppl 26):S3286-S3289. doi: 10.21037/jtd.2018.08.116. No abstract available.

18.

Learning curve for uniportal video-assisted thoracoscopic surgery lobectomy-results from 120 consecutive patients.

Liu X, Chen X, Shen Y, Wang H, Feng M, Tan L, D'Amico TA.

J Thorac Dis. 2018 Aug;10(8):5100-5107. doi: 10.21037/jtd.2018.08.87.

19.

General thoracic surgical training in North America: Contrasting general thoracic surgery residencies in Canada and the United States.

Schieman C, Seder CW, D'Amico TA, Grondin SC.

J Thorac Cardiovasc Surg. 2018 Dec;156(6):2379-2387. doi: 10.1016/j.jtcvs.2018.07.016. Epub 2018 Jul 20. No abstract available.

PMID:
30139643
20.

Comment on "Early Feeding After Esophagectomy: Show Must Go On".

Moris D, D'Amico TA.

Ann Surg. 2019 Jul;270(1):e8. doi: 10.1097/SLA.0000000000002984. No abstract available.

PMID:
30048314
21.
22.

NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018.

Ettinger DS, Aisner DL, Wood DE, Akerley W, Bauman J, Chang JY, Chirieac LR, D'Amico TA, Dilling TJ, Dobelbower M, Govindan R, Gubens MA, Hennon M, Horn L, Lackner RP, Lanuti M, Leal TA, Lilenbaum R, Lin J, Loo BW, Martins R, Otterson GA, Patel SP, Reckamp K, Riely GJ, Schild SE, Shapiro TA, Stevenson J, Swanson SJ, Tauer K, Yang SC, Gregory K, Hughes M.

J Natl Compr Canc Netw. 2018 Jul;16(7):807-821. doi: 10.6004/jnccn.2018.0062.

PMID:
30006423
23.

Higher Use of Surgery Confers Superior Survival in Stage I Non-Small Cell Lung Cancer.

Mulvihill MS, Cox ML, Becerra DC, Watson JA, Voigt SL, Yerokun BA, Speicher PJ, D'Amico TA, Tong B, Hartwig MG.

Ann Thorac Surg. 2018 Nov;106(5):1533-1540. doi: 10.1016/j.athoracsur.2018.05.066. Epub 2018 Jun 28.

PMID:
29959940
24.

Surgical treatment for early stage non-small cell lung cancer.

Raman V, Yang CJ, Deng JZ, D'Amico TA.

J Thorac Dis. 2018 Apr;10(Suppl 7):S898-S904. doi: 10.21037/jtd.2018.01.172. Review.

25.

Oncologic Equivalence of Minimally Invasive Lobectomy: The Scientific and Practical Arguments.

Demmy TL, Yendamuri S, D'Amico TA, Burfeind WR.

Ann Thorac Surg. 2018 Aug;106(2):609-617. doi: 10.1016/j.athoracsur.2018.02.089. Epub 2018 Apr 17. Review.

PMID:
29678519
26.

Less is sometimes less.

D'Amico TA.

J Thorac Cardiovasc Surg. 2018 Jun;155(6):2657. doi: 10.1016/j.jtcvs.2018.02.053. Epub 2018 Mar 2. No abstract available.

PMID:
29627181
27.

Milestones in thoracic surgery.

Khaitan PG, D'Amico TA.

J Thorac Cardiovasc Surg. 2018 Jun;155(6):2779-2789. doi: 10.1016/j.jtcvs.2017.12.149. Epub 2018 Feb 13. Review.

PMID:
29501230
28.

Survival after radiation for stage I and II non-small cell lung cancer with positive margins.

Gulack BC, Cox ML, Yang CJ, Speicher PJ, Kara HV, D'Amico TA, Berry MF, Hartwig MG.

J Surg Res. 2018 Mar;223:94-101. doi: 10.1016/j.jss.2017.10.025. Epub 2017 Nov 14.

PMID:
29433891
29.

Thoracoscopic lobectomy after induction therapy-a paradigm shift?

Hirji SA, Osho A, Balderson SS, D'Amico TA.

J Vis Surg. 2017 Dec 21;3:189. doi: 10.21037/jovs.2017.12.10. eCollection 2017.

30.

Uniportal lobectomy and segmentectomy-is it for all?

Hirji SA, Balderson SS, D'Amico TA.

J Vis Surg. 2017 Dec 7;3:180. doi: 10.21037/jovs.2017.11.09. eCollection 2017.

31.

Long-term outcomes of surgical resection for stage IV non-small-cell lung cancer: A national analysis.

Yang CJ, Gu L, Shah SA, Yerokun BA, D'Amico TA, Hartwig MG, Berry MF.

Lung Cancer. 2018 Jan;115:75-83. doi: 10.1016/j.lungcan.2017.11.021. Epub 2017 Nov 23.

PMID:
29290266
32.

Design of interventional studies in thoracic surgery.

Fitch ZW, Deng JZ, Yang CJ, D'Amico TA.

J Thorac Dis. 2017 Oct;9(10):4114-4116. doi: 10.21037/jtd.2017.09.04.

33.

Surgical Outcomes After Neoadjuvant Chemotherapy and Ipilimumab for Non-Small Cell Lung Cancer.

Yang CJ, McSherry F, Mayne NR, Wang X, Berry MF, Tong B, Harpole DH Jr, D'Amico TA, Christensen JD, Ready NE, Klapper JA.

Ann Thorac Surg. 2018 Mar;105(3):924-929. doi: 10.1016/j.athoracsur.2017.09.030. Epub 2017 Dec 16.

PMID:
29258674
34.

Patterns of Treatment and Outcomes for Definitive Therapy of Early Stage Non-Small Cell Lung Cancer.

Kapadia NS, Valle LF, George JA, Jagsi R, D'Amico TA, Dexter EU, Vigneau FD, Kong FM.

Ann Thorac Surg. 2017 Dec;104(6):1881-1888. doi: 10.1016/j.athoracsur.2017.06.065. Epub 2017 Oct 26.

PMID:
29106887
35.

Anatomic thoracoscopic segmentectomy for early-stage lung cancer.

Yang CJ, Fitch ZW, Balderson SS, Deng JZ, D'Amico TA.

J Vis Surg. 2017 Sep 14;3:123. doi: 10.21037/jovs.2017.08.19. eCollection 2017. Review.

36.

Undoing the gaps in quality, cost, and value.

D'Amico TA.

J Thorac Cardiovasc Surg. 2018 Mar;155(3):1211. doi: 10.1016/j.jtcvs.2017.09.022. Epub 2017 Sep 18. No abstract available.

PMID:
28987737
37.

Immune Activation in Early-Stage Non-Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab.

Yi JS, Ready N, Healy P, Dumbauld C, Osborne R, Berry M, Shoemaker D, Clarke J, Crawford J, Tong B, Harpole D, D'Amico TA, McSherry F, Dunphy F, McCall SJ, Christensen JD, Wang X, Weinhold KJ.

Clin Cancer Res. 2017 Dec 15;23(24):7474-7482. doi: 10.1158/1078-0432.CCR-17-2005. Epub 2017 Sep 26.

38.

Impact of Timing of Lobectomy on Survival for Clinical Stage IA Lung Squamous Cell Carcinoma.

Yang CJ, Wang H, Kumar A, Wang X, Hartwig MG, D'Amico TA, Berry MF.

Chest. 2017 Dec;152(6):1239-1250. doi: 10.1016/j.chest.2017.07.032. Epub 2017 Aug 8.

PMID:
28800867
39.

A National Analysis of Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Stage I Non-small-cell Lung Cancer.

Yang CJ, Kumar A, Klapper JA, Hartwig MG, Tong BC, Harpole DH Jr, Berry MF, D'Amico TA.

Ann Surg. 2019 Jan;269(1):163-171. doi: 10.1097/SLA.0000000000002342.

PMID:
28799982
40.

Adjuvant Chemotherapy Does Not Confer Superior Survival in Patients With Atypical Carcinoid Tumors.

Anderson KL Jr, Mulvihill MS, Speicher PJ, Yerokun BA, Gulack BC, Nussbaum DP, Harpole DH Jr, D'Amico TA, Berry MF, Hartwig MG.

Ann Thorac Surg. 2017 Oct;104(4):1221-1230. doi: 10.1016/j.athoracsur.2017.05.011. Epub 2017 Jul 29.

41.

Minimally Invasive Thoracic Surgery 3.0: Lessons Learned From the History of Lung Cancer Surgery.

Cheng X, Onaitis MW, D'amico TA, Chen H.

Ann Surg. 2018 Jan;267(1):37-38. doi: 10.1097/SLA.0000000000002405. Review. No abstract available.

PMID:
28692471
42.

Segmentectomy and Lung Cancer: Why, When, How, and How Good?

Landreneau RJ, D'Amico TA, Schuchert MJ, Swanson SJ.

Semin Thorac Cardiovasc Surg. 2017 Spring;29(1):119-128. doi: 10.1053/j.semtcvs.2017.04.003. Epub 2017 Apr 6. No abstract available.

PMID:
28683989
43.

Surgical resection after neoadjuvant chemoradiation for oesophageal adenocarcinoma: what is the optimal timing?

Ranney DN, Mulvihill MS, Yerokun BA, Fitch Z, Sun Z, Yang CF, D'Amico TA, Hartwig MG.

Eur J Cardiothorac Surg. 2017 Sep 1;52(3):543-551. doi: 10.1093/ejcts/ezx132.

PMID:
28498967
44.

Long-term Survival After Surgery Compared With Concurrent Chemoradiation for Node-negative Small Cell Lung Cancer.

Yang CJ, Chan DY, Shah SA, Yerokun BA, Wang XF, D'Amico TA, Berry MF, Harpole DH Jr.

Ann Surg. 2018 Dec;268(6):1105-1112. doi: 10.1097/SLA.0000000000002287.

PMID:
28475559
45.

A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non-small cell lung cancer.

Yerokun BA, Yang CJ, Gulack BC, Li X, Mulvihill MS, Gu L, Wang X, Harpole DH, D'Amico TA, Berry MF, Hartwig MG.

J Thorac Cardiovasc Surg. 2017 Aug;154(2):675-686.e4. doi: 10.1016/j.jtcvs.2017.02.065. Epub 2017 Apr 4.

46.

Get it right the first time.

D'Amico TA.

J Thorac Cardiovasc Surg. 2017 Aug;154(2):650-651. doi: 10.1016/j.jtcvs.2017.03.126. Epub 2017 Apr 5. No abstract available.

47.

Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.

Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman J, Chirieac LR, D'Amico TA, DeCamp MM, Dilling TJ, Dobelbower M, Doebele RC, Govindan R, Gubens MA, Hennon M, Horn L, Komaki R, Lackner RP, Lanuti M, Leal TA, Leisch LJ, Lilenbaum R, Lin J, Loo BW Jr, Martins R, Otterson GA, Reckamp K, Riely GJ, Schild SE, Shapiro TA, Stevenson J, Swanson SJ, Tauer K, Yang SC, Gregory K, Hughes M.

J Natl Compr Canc Netw. 2017 Apr;15(4):504-535.

PMID:
28404761
48.

Induction chemotherapy for T3N0M0 non-small-cell lung cancer increases the rate of complete resection but does not confer improved survival.

Anderson KL Jr, Mulvihill MS, Yerokun BA, Speicher PJ, D'Amico TA, Tong BC, Berry MF, Hartwig MG.

Eur J Cardiothorac Surg. 2017 Aug 1;52(2):370-377. doi: 10.1093/ejcts/ezx091.

49.

Surgery Versus Optimal Medical Management for N1 Small Cell Lung Cancer.

Yang CJ, Chan DY, Speicher PJ, Gulack BC, Tong BC, Hartwig MG, Kelsey CR, D'Amico TA, Berry MF, Harpole DH.

Ann Thorac Surg. 2017 Jun;103(6):1767-1772. doi: 10.1016/j.athoracsur.2017.01.043. Epub 2017 Apr 25.

PMID:
28385378
50.

Traveling to a High-volume Center is Associated With Improved Survival for Patients With Esophageal Cancer.

Speicher PJ, Englum BR, Ganapathi AM, Wang X, Hartwig MG, D'Amico TA, Berry MF.

Ann Surg. 2017 Apr;265(4):743-749. doi: 10.1097/SLA.0000000000001702.

Supplemental Content

Loading ...
Support Center